We’re proud to announce the #FDA approval of two new treatment combinations for certain patients with muscle-invasive #BladderCancer (MIBC). This milestone, in collaboration with Pfizer and Astellas Pharma, is an important step in bladder cancer care for more patients. Learn more: http://merck.us/4pnYZkr
My father has passed and had bladder cancer. My hope is to have more screening and better more wholistic treatment earlier IOs, new therapies, and regular treatment to be incorporated into the options. Even when he thought he was cancer free it was still lurking in his body despite regular check ups and scraping procedures. I am grateful to know the science has advanced and continues everyday to help more patients and their loved ones.
Thank you for sharing
Huge progress, congratulations!
Actually I write pharma
MSD continues to show what true leadership in science looks like joining hands with partners across the world to bring breakthroughs to patients who need them most. Collaboration humanity over everything. Proud to be part of MSD.
Fantastic milestone for Merck! 👏💙 Congratulations on the FDA approval of these new treatment combinations — a meaningful step forward for patients with muscle-invasive bladder cancer. Great to see such strong collaboration with Pfizer and Astellas Pharma driving innovation in oncology. Proud to see Merck continuing to advance care for those who need it most. #BladderCancer #Oncology #Merck
My grandma died of bladder cancer so these news hit differently. Glad we’re bringing hope to patients and families affected by this terrible disease ♥️
Remarkable milestone in bladder cancer care. As a recruiter specializing in oncology, clinical development, and translational science, I work with exceptional talent who are eager to contribute to advancements like this. Would welcome the opportunity to support Merck’s teams driving this important work forward. Congratulations to all involved.